Physician profile
Marc J Pinsky
NPI 1174590186
$2,090.13
in general payments reported to CMS, 2019-2025
14 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2022: $326 · 2023: $371 · 2024: $475 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $329.25 | 2022-2024 | |
| Kerecis Limited | $280.98 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $240.91 | 2023-2025 | |
| Melinta Therapeutics, LLC | $125.00 | 2019 | |
| Amgen INC. | $124.98 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $119.29 | 2023 | Krystexxa |
| Ani Pharmaceuticals, INC. | $117.40 | 2025 | Purified Cortrophin Gel |
| Organogenesis INC. | $116.72 | 2025 | Novachor, Affinity |
| Vertex Pharmaceuticals Incorporated | $112.65 | 2025 | |
| In2bones USA, LLC | $110.13 | 2022 | |
| Wright Medical Technology, INC. | $109.77 | 2019 | |
| Medtronic, INC. | $105.52 | 2024 | |
| Smith+Nephew, INC. | $103.01 | 2022 | |
| Kci USA, INC. | $94.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Pinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.